Skip to main content
. Author manuscript; available in PMC: 2021 Jun 16.
Published in final edited form as: J Allergy Clin Immunol Pract. 2015 Feb 11;3(3):400–407. doi: 10.1016/j.jaip.2014.12.007

TABLE I.

Demographics of the study cohort of adult patients with chronic urticaria

Characteristics Total (%)* Female (%)* Male (%)* P-value

No. of patients 221 165 (74.7) 56 (25.3) <.01
Mean age at the first clinic visit (y) (mean ± SD) 42.8 ± 12.2 41.1 ± 11.9 47.7 ± 11.9 <.01
Caucasian race 157 (83.5) 115 (82.1) 42 (87.5) NS
Duration of CU before the first clinic visit (y) (mean ± SD) 3.2 ± 6.9 3.1 ± 6.6 3.6 ± 7.7 NS
Achieved control during any clinic visit (F: n = 165; M: n = 56) 140 (63.4) 101 (72.1) 39 (69.6) NS
Episodes lasting >48 h (F: n = 89; M: n = 36) 70 (56) 50 (56.2) 20 (55.6) NS
Associated angioedema (F: n = 149; M: n = 50) 152 (76.4) 111 (74.5) 41 (82) NS
Associated dermatographia (F: n = 119; M: n = 34) 61 (39.9) 56 (47.1) 5 (14.7) <.01
Associated physical urticaria(s) (F: n = 89; M: n = 34) 120 (66.3) 96 (70.1) 24 (54.6) .05
History of smoking (F: n = 158; M: n = 53) 58 (27.5) 37 (23.4) 21 (39.6) .02
History of thyroid disease§ (F: n = 158; M: n = 55) 32 (15) 27 (17.1) 5 (9.1) NS
History of autoimmune disease§ (F: n = 155; M: n = 54) 25 (12) 16 (10.3) 9 (16.7) NS
FHx of CU (F: n = 145; M: n = 49) 32 (16.5) 25 (17.2) 7 (14.3) NS
FHx of autoimmune disease (F: n = 138; M: n = 48) 42 (22.6) 33 (23.9) 9 (18.8) NS

FHx, family history; NS, not significant at P = .05.

*

Percent represents total of the column or row.

Numbers represent the total number of male and female patients who reported this information.

Other than dermatographia included cold (n = 12), delayed pressure (n = 2), pressure (n = 60), exercise (n = 33), cholinergic (n = 36), solar (n = 6), vibratory (n = 1), and aquagenic (n = 6).

§

Based on the patient report; autoimmune disease included the report of endocrine, rheumatologic or hematologic disorders.